Basic HTML Version
Ελληνική Ακτινολογία, Τόμος 43, Τεύχος 4, 2012
248
imaging somatotopy and individual brain anatomy
of the central region: comparison with intraoperative
stimulation in patients with brain tumors. J Neurosurg
2000;92:589-98.
62. Krainik A, Lehericy S, Duffau H, et al. Role of the
supplementary motor area in motor deficit following
medial frontal lobe surgery. Neurology 2001;57:871-8.
63. Rasmussen T, Milner B. The role of early left-brain injury
in determining lateralization of cerebral speech func-
tions. Ann N Y Acad Sci 1977;299:355-69.
64. Tomczak RJ, Wunderlich AP, Wang Y, et al. fMRI for
preoperative neurosurgical mapping of motor cortex and
language in a clinical setting. J Comput Assist Tomogr
2000; 24:927-34.
65. Benson RR, FitzGerald DB, LeSueur LL, et al. Language
dominance determined by whole brain functional MRI
in patients with brain lesions. Neurology 1999; 52:798-
809.
66. Lehericy S, Cohen L, Bazin B, Samson S, et al.
Functional MR evaluation of temporal and frontal
language dominance compared with the Wada test.
Neurology 2000;54:1625-33.
67. Woermann FG, Jokeit H, Luerding R, et al. Language
lateralization by Wada test and fMRI in 100 patients with
epilepsy. Neurology 2003;61:699-701.
68. Federico P, Archer JS, Abbott DF, Jackson GD. Cortical/
subcortical BOLD changes associated with epileptic
discharges: an EEG-fMRI study at 3 T. Neurology 2005;
64:1125-30.
69. WardNS. Functional reorganizationof thecerebralmotor
system after stroke. Curr Opin Neurol 2004;17:725-
30.
70. Lemieux L, Salek-Haddadi A, Josephs O, et al. Event-
related fMRI with simultaneous and continuous EEG:
description of the method and initial case report.
Neuroimage 2001;14:780-7.
71. Marshall I, Wardlaw J, Cannon J, et al. Reproducibility
of metabolite peak areas in 1H MRS of brain. Magn
Reson Imaging 1996;14(3):281–92.
72. Calvar JA. Accurate (1)H tumor spectra quantification
from acquisitions without water suppression. Magn
Reson Imaging 2006;24(9):1271–9.
73. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a
literature review of a compound prominent in 1H-NMR
spectroscopic studies of brain. Neurosci Biobehav Rev
1989; 13(1):23–31.
74. Moffett JR, Ross B, Arun P, et al. N-acetyl aspartate in
the CNS: from neurodiagnostics to neurobiology. Prog
Neurobiol 2007;81(2):89–131.
75. Wyss M, Kaddurah-Daouk R. Creatine and creatinine
metabolism. Physiol Rev 2000; 80(3):1107–213.
76. ChristiansenP,ToftP,LarssonHB,etal.Theconcentration
of N-acetyl aspartate, creatine- phosphocreatine, and
choline in different parts of the brain in adulthood and
senium. Magn Reson Imaging 1993;11(6):799–806.
77. Brief EE, Whittall KP, Li DK, et al. Proton T1 relaxation
times of cerebral metabolites differ within and between
regions of normal human brain. NMR Biomed
2003;16(8):503–9.
78. Degaonkar MN, Pomper MG, Barker PB. Quantitative
proton magnetic resonance spectroscopic imaging:
regional variations in the corpus callosum and cortical
gray matter. J Magn Reson Imaging 2005;22(2):175–
9.
79. Kent C. Regulatory enzymes of phosphatidylcholine
biosynthesis: a personal perspective [review]. Biochim
Biophys Acta 2005;1733(1):53–66.
80. Babb SM, Ke Y, Lange N, et al. Oral choline increases
choline metabolites in human brain. Psychiatry Res
2004;130(1):1–9.
81. Cho YD, Choi GH, Lee SP, et al. (1)H-MRS metabolic
patterns for distinguishing between meningiomas
and other brain tumors. Magn Reson Imaging
2003;21(6):663–72.
82. Gajewicz W, Papierz W, Szymczak W, et al. The use
of proton MRS in the differential diagnosis of brain
tumors and tumor like processes. Med Sci Monit
2003;9(9):MT97–T105.
83. Preul MC, Caramanos Z, Collins DL, et al. Accurate,
noninvasive diagnosis of human brain tumors by using
proton magnetic resonance spectroscopy. Nat Med
1996;2:323–5.
84. Del Sole A, Falini A, Ravasi L, et al. Anatomical and
biochemical investigation of primary brain tumours
[review]. Eur J Nucl Med 2001;28(12):1851–72.
85. Delorme S, Weber MA. Applications of MRS in the
evaluation of focal malignant brain lesions. Cancer
Imaging 2006;22(6):95–9.
86. Lai PH, Ho JT, Chen WL, et al. Brain abscess and
necrotic brain tumor: discrimination with proton MR
spectroscopy and diffusion-weighted imaging. AJNR
Am J Neuroradiol 2002;23(8):1369–77.
87. Devos A, Lukas L, Suykens JA, et al. Classification of
brain tumours using short echo time 1H MR spectra. J
Magn Reson 2004;170:164–75.
88. Li X, Vigneron DB, Cha S, et al. Relationship of
MR-derived lactate, mobile lipids, and relative blood
volume for gliomas in vivo. AJNR Am J Neuroradiol
2005;26(4):760–9.
89. Law M, Yang S, Wang H, et al. Glioma grading:
sensitivity, specificity, and predictive values of perfusion
MR imaging and proton MR spectroscopic imaging
compared with conventional MR imaging. AJNR Am J
Neuroradiol 2003;24(10):1989–98.
90. Fayed N, Morales H, Modrego PJ, et al. Contrast/noise
ratio on conventional MRI and choline/creatine ratio on
proton MRI spectroscopy accurately discriminate low-
grade from high-grade cerebral gliomas. Acad Radiol
2006;13(6):728–37.
91. Chen J, Huang SL, Li T, et al. In vivo research
in astrocytoma cell proliferation with 1Hmagnetic
resonance spectroscopy: correlation with histopathology
and immunoh i s t ochemi s t r y . Neuror ad i o l ogy
2006;48(5):312–8.